Literature DB >> 8310204

Influence of dichloromethylene diphosphonate on reactive oxygen species production by human neutrophils.

R Serretti1, P Core, S Muti, F Salaffi.   

Abstract

Biphosphonates suppress bone destruction in various diseases. Several studies have demonstrated the potential use of biphosphonate in arthritis. The results of these studies indicate that the effectiveness of the biphosphonates, for inhibiting the arthritic process, is related to their antiresorptive properties. It has been shown that the generation of reactive oxygen species is associated with the formation of new osteoclasts and enhanced bone resorption. We studied the effects of the dichloromethylene diphosphonate on the reactive oxygen species production by activated polymorphonuclear leucocytes, measured by chemiluminescence. Our results indicate a dose-dependent inhibitory effect of dichloromethylene diphosphonate on reactive oxygen species production by polymorphonuclear leucocytes stimulated with N-formil-methionyl-leucyl-phenylalanine, the calcium ionophore A23187 and phorbol myristate acetate. The mechanisms by which this biphosphonate inhibits the reactive oxygen species production by activated polymorphonuclear leucocytes are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8310204     DOI: 10.1007/BF00301259

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  30 in total

Review 1.  The O2- -forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function.

Authors:  F Rossi
Journal:  Biochim Biophys Acta       Date:  1986-11-04

2.  A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

Review 3.  [Toxicity of oxygen, free radicals and defense mechanisms].

Authors:  C Deby; J Pincemail
Journal:  Presse Med       Date:  1986-09-25       Impact factor: 1.228

4.  H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells.

Authors:  R K Root; J A Metcalf
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

Review 5.  Experimental basis for the use of bisphosphonates in Paget's disease of bone.

Authors:  H Fleisch
Journal:  Clin Orthop Relat Res       Date:  1987-04       Impact factor: 4.176

6.  Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD).

Authors:  P J Ryan; M Sherry; T Gibson; I Fogelman
Journal:  Br J Rheumatol       Date:  1992-02

7.  The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat.

Authors:  S C Miller; W S Jee
Journal:  Anat Rec       Date:  1979-03

8.  Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

9.  Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.

Authors:  P M Boonekamp; L J van der Wee-Pals; M M van Wijk-van Lennep; C W Thesing; O L Bijvoet
Journal:  Bone Miner       Date:  1986-02

10.  Clodronate kinetics and dynamics.

Authors:  K A Conrad; S M Lee
Journal:  Clin Pharmacol Ther       Date:  1981-07       Impact factor: 6.875

View more
  6 in total

1.  Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules.

Authors:  Gloria Lopez-Castejón; Alberto Baroja-Mazo; Pablo Pelegrín
Journal:  Cell Mol Life Sci       Date:  2010-12-28       Impact factor: 9.261

2.  Zoledronate and pamidronate depress neutrophil functions and survival in mice.

Authors:  J W P Kuiper; C Forster; C Sun; S Peel; M Glogauer
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

3.  Effects of clodronate and alendronate on local and systemic changes in bone metabolism in rats with adjuvant arthritis.

Authors:  Fumiaki Itoh; Shigemi Aoyagi; Hiroshi Kusama; Masami Kojima; Hiroshi Kogo
Journal:  Inflammation       Date:  2004-02       Impact factor: 4.092

Review 4.  Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  G L Plosker; K L Goa
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

5.  Modulating P2X7 Receptor Signaling during Rheumatoid Arthritis: New Therapeutic Approaches for Bisphosphonates.

Authors:  Alberto Baroja-Mazo; Pablo Pelegrín
Journal:  J Osteoporos       Date:  2012-07-08

6.  Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates.

Authors:  Pablo Pelegrin; Annmarie Surprenant
Journal:  EMBO J       Date:  2009-06-18       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.